Inhibition of FXIIIa Activity in Platelet Homogenates by Anti-FXIIIA Antiserum
| . | dpm/μg/min . | % Inhibition . | |
|---|---|---|---|
| . | Without Anti-FXIIIA . | With Anti-FXIIIA . | . |
| Control | 263 | 25 | 90 |
| Patient II-1 | 0.93 | 0.3 | 68 |
| Patient II-3 | 0.92 | 0.1 | 89 |
| Carrier III-1 | 78 | 10 | 87 |
| Carrier III-2 | 119 | 10 | 91 |
| . | dpm/μg/min . | % Inhibition . | |
|---|---|---|---|
| . | Without Anti-FXIIIA . | With Anti-FXIIIA . | . |
| Control | 263 | 25 | 90 |
| Patient II-1 | 0.93 | 0.3 | 68 |
| Patient II-3 | 0.92 | 0.1 | 89 |
| Carrier III-1 | 78 | 10 | 87 |
| Carrier III-2 | 119 | 10 | 91 |